Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

EMA approves Samsung Bioepis's biosimilar etanercept Benepali

Jan. 18, 2016

AbbVie begins phase III program evaluating ABT-494 for rheumatoid arthritis

Jan. 11, 2016

FDA accepts for review sarilumab BLA for rheumatoid arthritis

Jan. 8, 2016

Mice homozygous for LGMD2I-causing FKRP mutation show progressive myopathy

Jan. 8, 2016

Novel preclinical model for cancer cachexia

Dec. 30, 2015

PI3Kdelta inhibitors revealed in Merck & Co. patent

Dec. 29, 2015

Biosimilar adalimumab M-923 met primary endpoint in pharmacokinetic study

Dec. 24, 2015

Cell therapy improves functional and structural outcome after muscle trauma

Dec. 23, 2015

Galapagos and Gilead Sciences partner to develop filgotinib for inflammatory diseases

Dec. 17, 2015

TEI-SARM2 shows promise for the treatment of muscle wasting diseases

Dec. 11, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...